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AT A GLANCE
Population: 263,991,379
Per capita income: $11,900
Life expectancy at birth: F 71/M 67 years
Infant mortality rate: 22/1,000 live births
TOP 10 CAUSES OF DEATH
1.     Stroke
2.     lschemic heart disease
3.     Diabetes
4.     Cirrhosis
5.     Tuberculosis
6.     Chronic obstructive pulmonary disease
7.     Diarrheal diseases
8.     Road injuries
9.     Chronic kidney disease
10.   Lower respiratory infections
CDC STAFF
2     U.S. Assignees   
4     Locally Employed
Global Health Security 
CDC’s global health security efforts in Indonesia help improve the country’s 
ability to prevent, detect, and respond to infectious disease outbreaks before 
they become epidemics that could affect global populations. These efforts 
help Indonesia reach the targets outlined in the Global Health Security Agenda 
(GHSA), a global partnership launched in 2014 to help make the world safer and 
more secure from infectious disease threats. 
Working closely with the Ministry of Health (MOH) and other partners, CDC 
provides expertise and support across the 11 technical areas known as GHSA 
action packages. These action packages help Indonesia build core public health 
capacities in disease surveillance, laboratory systems, workforce development, 
emergency management, and other critical areas.
Vaccine-Preventable Diseases
Vaccines prevent an estimated 2.5 million deaths among children under 5 
years of age annually. Still, 1 child dies every 20 seconds from a disease that 
could have been prevented by a vaccine. CDC provides support to countries to 
strengthen vaccine-preventable disease detection and vaccine delivery. Our 
goal is to provide scientific and public health expertise, making evidence for 
action available for optimal policy and programmatic decision-making at all 
levels, from community to global. Two locally employed staff assigned to CDC 
Indonesia support country-wide immunization and vaccine-preventable disease 
surveillance systems strengthening. Program objectives include maintaining a 
polio-free status, working toward measles and rubella elimination, introducing 
new vaccines (such human papillomavirus, Japanese encephalitis, rotavirus, 
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pneumococcal, and influenza) and improving routine immunization coverage 
across the country.
Malaria
Malaria causes several hundred thousand infections and approximately 2,000 
deaths each year in Indonesia. Progress toward malaria elimination has been 
made in the western part of the country but is stagnant in Papua Province, 
which accounts for 74% of reported cases annually. Malaria control and 
elimination work is made in collaboration with the MOH, the National Malaria 
Control Program (NMCP), UNICEF, and WHO. CDC supports elimination work 
in the western part of the country, development of laboratory infrastructure 
and reporting, and improved control in Papua Province. CDC supported the 
Global Fund to Fight AIDS, Tuberculosis and Malaria grant for Indonesia, 
focused on improving program management in Papua and implementation of 
key research associated with hard to reach populations, migration, insecticide 
resistance management, and development of laboratory networks for 
improved surveillance.
Influenza 
Influenza viruses are constantly changing and require continued vigilance 
to protect the United States and the world from seasonal influenza and 
from novel viruses that could trigger a pandemic. CDC has worked with 
Indonesia to build surveillance and laboratory capacity to prevent, detect, and 
respond to influenza threats. CDC continues to encourage routine influenza 
surveillance, laboratory testing for influenza, reporting of laboratory results 
to the WHO global system, and the integration of surveillance with disease 
program policy development. Surveillance systems have expanded to 
examine other public health priorities such as pneumonia and dengue.  
Emerging Infectious Diseases
Infectious diseases can emerge without warning and quickly spread in our 
globally connected world, where their effects can have unprecedented reach. 
CDC works with Indonesia to help build surveillance and laboratory capacity 
to prevent, detect, and respond to infectious disease threats. CDC helped 
develop, train and equip a world-class laboratory at the Eijkman Institute of 
Molecular Biology in Jakarta for detection of emerging viruses and vector-
borne pathogens. The project connects researchers at the institute, medical 
schools, and the MOH to identify the causes of undifferentiated febrile illness.
Antimicrobial Resistance
Infections caused by bacteria resistant to one or more antibiotics have 
become challenges. CDC works with Indonesia to build surveillance and 
laboratory capacity to identify and characterize pathogens resistant to 
antibiotics. Technical support was provided for development of a reference 
laboratory at the Eijkman Institute of Molecular Biology in Jakarta for 
detection of WHO priority antimicrobial resistant (AMR) pathogens. CDC and 
Eijkman staff are working in collaboration with the National AMR Committee 
to establish clinical laboratory capacity for the detection of bacterial 
pathogens causing infections in patients hospitalized with meningitis, 
pneumonia, and sepsis.
Field Epidemiology Training Program 
CDC supports Indonesia in strengthening the capacity of its workforce to 
investigate and respond to disease outbreaks through the establishment of a 
Field Epidemiology Training Program (FETP). FETP trains a workforce of field 
epidemiologists—or disease detectives—to identify and contain outbreaks 
before they become epidemics. Participants develop the skills to gather 
critical data and turn it into evidence-base action. The FETP in Indonesia 
evolved into a Master’s Program at the Universities of Indonesia, Gadjah 
Mada, Airlangga, Udayana and Hasanuddin. CDC provided the support of an 
in-country resident advisor to strengthen field assignments and to provide 
essential mentorship and instruction on special topics, such as investigating 
infectious disease outbreaks, scientific writing, and communication.
CDC IMPACT IN INDONESIA
As of March 2018, more than 690 
fellows have graduated from the Field 
Epidemiology Training Program and are 
assuming public health leadership positions 
in Indonesia and other countries in the 
region.
Four Ministry of Health staff have 
participated in the CDC Public Health 
Emergency Management Fellowship 
Program. They helped establish a Public 
Health Emergency Operations Center within 
the Indonesia MOH.
Established sentinel surveillance for 
leptospirosis, a bacterial disease that 
affects humans and animals, in two district 
hospitals and eight community health 
centers in Jakarta Province. The program is 
now being expanded to additional health 
care facilities in East Java province.
For more country information, visit: 
www.cdc.gov/globalhealth/countries/indonesia
